BOLD
Price
$2.53
Change
-$0.01 (-0.39%)
Updated
Jan 17 closing price
Capitalization
56.42M
39 days until earnings call
TNXP
Price
$0.24
Change
+$0.01 (+4.35%)
Updated
Jan 17 closing price
Capitalization
44.01M
58 days until earnings call
Ad is loading...

BOLD vs TNXP

Header iconBOLD vs TNXP Comparison
Open Charts BOLD vs TNXPBanner chart's image
Boundless Bio
Price$2.53
Change-$0.01 (-0.39%)
Volume$139.15K
Capitalization56.42M
Tonix Pharmaceuticals Holding
Price$0.24
Change+$0.01 (+4.35%)
Volume$39.91M
Capitalization44.01M
BOLD vs TNXP Comparison Chart
Loading...
BOLD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TNXP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BOLD vs. TNXP commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BOLD is a Hold and TNXP is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (BOLD: $2.53 vs. TNXP: $0.24)
Brand notoriety: BOLD and TNXP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BOLD: 116% vs. TNXP: 33%
Market capitalization -- BOLD: $56.42M vs. TNXP: $44.01M
BOLD [@Biotechnology] is valued at $56.42M. TNXP’s [@Biotechnology] market capitalization is $44.01M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BOLD’s FA Score shows that 1 FA rating(s) are green whileTNXP’s FA Score has 1 green FA rating(s).

  • BOLD’s FA Score: 1 green, 4 red.
  • TNXP’s FA Score: 1 green, 4 red.
According to our system of comparison, both BOLD and TNXP are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BOLD’s TA Score shows that 3 TA indicator(s) are bullish while TNXP’s TA Score has 3 bullish TA indicator(s).

  • BOLD’s TA Score: 3 bullish, 5 bearish.
  • TNXP’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, BOLD is a better buy in the short-term than TNXP.

Price Growth

BOLD (@Biotechnology) experienced а +4.55% price change this week, while TNXP (@Biotechnology) price change was -15.50% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.65%, and the average quarterly price growth was -1.89%.

Reported Earning Dates

BOLD is expected to report earnings on Feb 26, 2025.

TNXP is expected to report earnings on May 19, 2025.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BOLD($56.4M) has a higher market cap than TNXP($44M). BOLD YTD gains are higher at: -12.759 vs. TNXP (-28.593). BOLD has higher annual earnings (EBITDA): -67.75M vs. TNXP (-76.74M). BOLD has more cash in the bank: 167M vs. TNXP (28.2M). BOLD has less debt than TNXP: BOLD (121K) vs TNXP (8.69M). TNXP has higher revenues than BOLD: TNXP (11.3M) vs BOLD (0).
BOLDTNXPBOLD / TNXP
Capitalization56.4M44M128%
EBITDA-67.75M-76.74M88%
Gain YTD-12.759-28.59345%
P/E RatioN/AN/A-
Revenue011.3M-
Total Cash167M28.2M592%
Total Debt121K8.69M1%
FUNDAMENTALS RATINGS
TNXP: Fundamental Ratings
TNXP
OUTLOOK RATING
1..100
72
VALUATION
overvalued / fair valued / undervalued
1..100
13
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BOLDTNXP
RSI
ODDS (%)
N/A
Bearish Trend 5 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
89%
Bullish Trend 5 days ago
85%
Momentum
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
90%
MACD
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
90%
Bullish Trend 5 days ago
79%
Advances
ODDS (%)
Bullish Trend 19 days ago
89%
Bullish Trend about 1 month ago
79%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
90%
Bearish Trend 5 days ago
84%
Aroon
ODDS (%)
Bearish Trend 5 days ago
90%
Bullish Trend 5 days ago
70%
View a ticker or compare two or three
Ad is loading...
BOLD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TNXP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X104462.0400004705.133000
+4.72%
Bitcoin cryptocurrency
TSLA426.5012.68
+3.06%
Tesla
SPY597.585.94
+1.00%
SPDR® S&P 500® ETF Trust
AAPL229.981.72
+0.75%
Apple
GME27.51-0.21
-0.76%
GameStop Corp

BOLD and

Correlation & Price change

A.I.dvisor indicates that over the last year, BOLD has been loosely correlated with KMSTF. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if BOLD jumps, then KMSTF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BOLD
1D Price
Change %
BOLD100%
-0.39%
KMSTF - BOLD
56%
Loosely correlated
N/A
KOD - BOLD
34%
Loosely correlated
-6.15%
TNXP - BOLD
27%
Poorly correlated
+0.21%
AKBA - BOLD
25%
Poorly correlated
+7.25%
GRI - BOLD
20%
Poorly correlated
+2.11%
More

TNXP and

Correlation & Price change

A.I.dvisor indicates that over the last year, TNXP has been closely correlated with NCNA. These tickers have moved in lockstep 90% of the time. This A.I.-generated data suggests there is a high statistical probability that if TNXP jumps, then NCNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TNXP
1D Price
Change %
TNXP100%
+0.21%
NCNA - TNXP
90%
Closely correlated
+2.70%
SNPX - TNXP
88%
Closely correlated
N/A
WINT - TNXP
88%
Closely correlated
-3.44%
RNAC - TNXP
88%
Closely correlated
+1.90%
CDTX - TNXP
87%
Closely correlated
+2.12%
More